B, C., C, M., M, W., & D, E. (2026). Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure. Journal of the American Society of Nephrology : JASN, 37(9), 1992-2003. https://doi.org/10.1681/ASN.0000001061
Παραπομπή σε μορφή Chicago (17η εκδ.)B, Catanese, Miller C, Wolf M, και Edmonston D. "Cardiovascular Outcomes Among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure." Journal of the American Society of Nephrology : JASN 37, no. 9 (2026): 1992-2003. https://doi.org/10.1681/ASN.0000001061.
Παραπομπή σε μορφή MLA (9th εκδ.)B, Catanese, et al. "Cardiovascular Outcomes Among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure." Journal of the American Society of Nephrology : JASN, vol. 37, no. 9, 2026, pp. 1992-2003, https://doi.org/10.1681/ASN.0000001061.